[HTML][HTML] Colon cancer and colorectal cancer: Prevention and treatment by potential natural products

MR Islam, S Akash, MM Rahman, FT Nowrin… - Chemico-biological …, 2022 - Elsevier
Colon cancer affects both men and women and is the world's second most significant cause
of cancer-related mortality. Colon cancer death rates have risen worldwide due to the …

[HTML][HTML] mTOR signaling in cancer and mTOR inhibitors in solid tumor targeting therapy

T Tian, X Li, J Zhang - International journal of molecular sciences, 2019 - mdpi.com
The mammalian or mechanistic target of rapamycin (mTOR) pathway plays a crucial role in
regulation of cell survival, metabolism, growth and protein synthesis in response to upstream …

[HTML][HTML] Mechanism of Sijunzi Decoction in the treatment of colorectal cancer based on network pharmacology and experimental validation

L Shang, Y Wang, J Li, F Zhou, K Xiao, Y Liu… - Journal of …, 2023 - Elsevier
Abstract Ethnopharmacological relevance Sijunzi Decoction (SJZD), as a famous classical
prescription for the treatment of colorectal cancer (CRC) in the traditional Chinese medicine …

[HTML][HTML] CircRNA_0000392 promotes colorectal cancer progression through the miR-193a-5p/PIK3R3/AKT axis

H Xu, Y Liu, P Cheng, C Wang, Y Liu, W Zhou… - Journal of Experimental …, 2020 - Springer
Abstract Background Circular RNAs (circRNAs), important members of the noncoding RNA
family, have been recently revealed to play a role in the pathogenic progression of diseases …

[HTML][HTML] A review of biological targets and therapeutic approaches in the management of triple-negative breast cancer

H Kumar, NV Gupta, R Jain… - Journal of Advanced …, 2023 - Elsevier
Background Triple-negative breast cancer (TNBC) is a heterogeneous, aggressive
phenotype of breast cancer with associated chemoresistance. The development of chemo-or …

[HTML][HTML] Natural products for treating colorectal cancer: A mechanistic review

X Huang, Z Yang, Q Xie, Z Zhang, H Zhang… - Biomedicine & …, 2019 - Elsevier
Colorectal cancer (CRC) is one of the most common types of cancers in humans and is
closely linked to the global cancer-related mortalities worldwide. Molecular pathological …

Phytosomal curcumin inhibits tumor growth in colitis‐associated colorectal cancer

RM Marjaneh, F Rahmani… - Journal of cellular …, 2018 - Wiley Online Library
Colorectal‐cancer (CRC) is the third leading cause of death due to cancer, supporting the
need for identification of novel anticancer drug to improve the efficacy of current‐therapy …

[HTML][HTML] Advances in the use of PARP inhibitor therapy for breast cancer

KE McCann, SA Hurvitz - Drugs in context, 2018 - ncbi.nlm.nih.gov
Abstract Poly-ADP-ribose polymerase 1 (PARP-1) and PARP-2 are DNA damage sensors
that are most active during S-phase of the cell cycle and that have wider-reaching roles in …

[HTML][HTML] Targeting lysyl oxidase family meditated matrix cross-linking as an anti-stromal therapy in solid tumours

YFI Setargew, K Wyllie, RD Grant, JL Chitty, TR Cox - Cancers, 2021 - mdpi.com
Simple Summary To improve efficacy of solid cancer treatment, efforts have shifted towards
targeting both the cancer cells and the surrounding tumour tissue they grow in. The lysyl …

[HTML][HTML] Exosomal miR-590-3p derived from cancer-associated fibroblasts confers radioresistance in colorectal cancer

X Chen, Y Liu, Q Zhang, B Liu, Y Cheng… - … Therapy-Nucleic Acids, 2021 - cell.com
Radiotherapeutic resistance is a major obstacle for the effective treatment of colorectal
cancer (CRC). MicroRNAs (miRNAs) play a critical role in chemoresistance and …